Standards of care (also called “standards of service”) offer guidance to providers in the care and treatment of people with bleeding disorders. In addition, these standards provide consumers with a set of necessary expectations associated with their pharmacy services and help to measure the quality of care they receive. It is critical that the care available to people living with bleeding disorders meets medically endorsed treatment standards and is not delayed or curtailed.
The Hemophilia Federation of America (HFA) expects that vendors or providers of clotting factor products (the main treatment for patients with bleeding disorders) adhere to reasonable and measurable standards of care. HFA supports the establishment, implementation and adherence to standards of care for providers of clotting factor concentrates and encourages state health agencies to work with patients to develop and implement standards of care.
The Medical and Scientific Advisory Council (MASAC), at the National Hemophilia Foundation, is an internationally recognized board of experts on bleeding disorders, and it has outlined a set of minimum standards that can be used as a model for providers of clotting factor concentrates. The MASAC Document 188 outlines standards that can potentially protect patients from undesirable health events.
Read more about Standards of Care in our issue brief.